Actively Recruiting
A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in Malaysia
Led by Takeda · Updated on 2025-06-12
2000
Participants Needed
2
Research Sites
136 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main aim of this study is to collect the number and type of medical problems (adverse events) after vaccination with QDENGA in Malaysia and to learn more about such medical problems after vaccination. Another aim of this study is to collect the number of persons vaccinated with QDENGA who need to stay in the hospital because of severe dengue fever. No vaccination will be given as part of this study. The study will only collect data of persons already vaccinated with QDENGA who agree to participate.
CONDITIONS
Official Title
A Study to Monitor the Adverse Events of QDENGA Vaccine in Participants in Malaysia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants who have received at least one dose of QDENGA vaccine in Malaysia during the study period.
- Participants or their legally authorized representative with a functioning phone number.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Universiti Malaya
Kuala Lumpur, Kuala Lumpur, Malaysia, 50603
Actively Recruiting
2
Universiti Putra Malaysia
Serdang, Selangor, Malaysia, 43400
Actively Recruiting
Research Team
T
Takeda Contact
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here